In conclusion, the current study clearly reveals that the platelet derived mRNA, ITGA2B and SELP are significantly increased in primary lung cancer patients thus could discriminating NSCLC and controls, and the combination of ITGA2B and CEA even performs better. This evidence concerns the gene CEACAM5 and lung cancer.